Cardiac MRI plays an important role in the evaluation of cardiovascular diseases (CVDs), including ischemic heart disease, cardiomyopathy, valvular disease, congenital disease …
Aims To determine the ranges of pre-test probability (PTP) of coronary artery disease (CAD) in which stress electrocardiogram (ECG), stress echocardiography, coronary computed …
E Nagel, JP Greenwood, GP McCann… - … England Journal of …, 2019 - Mass Medical Soc
Background In patients with stable angina, two strategies are often used to guide revascularization: one involves myocardial-perfusion cardiovascular magnetic resonance …
Task Force Members, G Montalescot… - European heart …, 2013 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what is recommended in the guidelines, thus completing the loop between clinical research …
G Mancia, R Fagard, K Narkiewicz… - Arterial …, 2013 - journals.viamedica.pl
Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …
SD Fihn, JM Gardin, J Abrams, K Berra… - Journal of the American …, 2012 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An extensive evidence review was conducted as the document was compiled through …
RY Kwong, Y Ge, K Steel, S Bingham… - Journal of the American …, 2019 - jacc.org
Background: Stress cardiac magnetic resonance imaging (CMR) has demonstrated excellent diagnostic and prognostic value in single-center studies. Objectives: This study …
J Lohrke, T Frenzel, J Endrikat, FC Alves, TM Grist… - Advances in …, 2016 - Springer
In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI), gadopentetate dimeglumine (Magnevist®), became available for clinical use. Since then, a …